Searchable abstracts of presentations at key conferences in endocrinology

ea0015p267 | Pituitary | SFEBES2008

Pituitary radiotherapy and cerebral blood flow: a transcranial Doppler in vivo investigation

Tooze Alana , Gittoes Neil , Jones Chris , Toogood Andrew

Background: Surgery, sometimes supported by adjunctive radiotherapy (RT), is the treatment of choice for patients with non-functioning pituitary adenoma (NFA). Previous studies have shown that patients treated with pituitary RT have doubling of mortality ratio due to cerebrovascular disease (CVD) but the reason for this excess is unclear. Transcranial Doppler (TCD) can be used to measure blood velocity in the middle cerebral arteries (MCAs) within the circle of Willis and also...

ea0013p229 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

The effects of radiotherapy on neurocognitive function in patients treated for non-functioning pituitary adenoma

Tooze Alana , Gittoes Neil , Jones Chris , Toogood Andrew

Background: Surgery, sometimes supported by adjunctive radiotherapy (RT) are the treatments of choice for patients with non-functioning pituitary adenomas (NFA). Previous studies have implicated these treatments in deficits of cognitive function, particularly memory and executive functioning, although this research has often been confounded by the inclusion of patients with hormone producing tumours. The aim of this study was to determine the impact of RT on psychometric funct...

ea0025oc2.1 | Steroids | SFEBES2011

Regulation of 11β-hydroxysteroid dehydrogenase type 1 by NF-κB in stromal cells: towards tissue specific enzyme inhibition

Ahasan Mohammad , Jones Chris , Hardy Rowan , Hassan-Smith Zaki , Lavery Gareth , Rabbitt Elizabeth , Buckley Cristopher , Raza Karim , Stewart Paul , Cooper Mark

The 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme is a tissue specific regulator of glucocorticoid action that is linked to the development of osteoporosis, inflammatory arthritis and myopathy. Systemic inhibition of 11β-HSD1 enzyme activity has been proposed as a therapeutic option in these conditions. However, 11β-HSD1 activity has also been reported to be important in regulation of the immune response and the HPA axis. We have previously demo...